TY - JOUR
T1 - Transcriptional down-regulation of epidermal growth factor receptors by nerve growth factor treatment of PC12 cells
AU - Shibutani, Makoto
AU - Lazarovici, Philip
AU - Johnson, Alfred C.
AU - Katagiri, Yasuhiro
AU - Guroff, Gordon
PY - 1998/3/20
Y1 - 1998/3/20
N2 - Treatment of PC12 cells with nerve growth factor leads to a decrease in the number of epidermal growth factor receptors on the cell membrane. The mRNA for the epidermal growth factor receptor decreases in a comparable fashion. This decrease appears due to a decrease in the transcription of the epidermal growth factor receptor gene because first, there is no difference in the stability of the epidermal growth factor receptor mRNA, second, newly transcribed epidermal growth factor receptor mRNA is decreased in nerve growth factor-differentiated cells, and third, constructs containing the promoter region of the epidermal growth factor receptor gene are transcribed much less readily in nerve growth factor-differentiated cells than in untreated cells. The decreases in mRNA are not seen in the p140(trk)- deficient variant PC12nnr5 cells nor in cells containing either dominant- negative Ras or dominant-negative Src. Treatment with nerve growth factor also increases the cellular content of GCF2, a putative transcription factor inhibitory for the transcription of the epidermal growth factor receptor gene. The increase in GCF2, like the decrease in the epidermal growth factor receptor mRNA, is not seen in PC12nnr5 cells nor in cells expressing either dominant-negative Ras or dominant-negative Src. The results suggest that nerve growth factor-induced down-regulation of the epidermal growth factor receptor is under transcriptional control, is p140(trk)-, Ras-, and Src- dependent, and may involve transcriptional repression by GCF2.
AB - Treatment of PC12 cells with nerve growth factor leads to a decrease in the number of epidermal growth factor receptors on the cell membrane. The mRNA for the epidermal growth factor receptor decreases in a comparable fashion. This decrease appears due to a decrease in the transcription of the epidermal growth factor receptor gene because first, there is no difference in the stability of the epidermal growth factor receptor mRNA, second, newly transcribed epidermal growth factor receptor mRNA is decreased in nerve growth factor-differentiated cells, and third, constructs containing the promoter region of the epidermal growth factor receptor gene are transcribed much less readily in nerve growth factor-differentiated cells than in untreated cells. The decreases in mRNA are not seen in the p140(trk)- deficient variant PC12nnr5 cells nor in cells containing either dominant- negative Ras or dominant-negative Src. Treatment with nerve growth factor also increases the cellular content of GCF2, a putative transcription factor inhibitory for the transcription of the epidermal growth factor receptor gene. The increase in GCF2, like the decrease in the epidermal growth factor receptor mRNA, is not seen in PC12nnr5 cells nor in cells expressing either dominant-negative Ras or dominant-negative Src. The results suggest that nerve growth factor-induced down-regulation of the epidermal growth factor receptor is under transcriptional control, is p140(trk)-, Ras-, and Src- dependent, and may involve transcriptional repression by GCF2.
UR - http://www.scopus.com/inward/record.url?scp=0032549584&partnerID=8YFLogxK
U2 - 10.1074/jbc.273.12.6878
DO - 10.1074/jbc.273.12.6878
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 9506991
AN - SCOPUS:0032549584
SN - 0021-9258
VL - 273
SP - 6878
EP - 6884
JO - Journal of Biological Chemistry
JF - Journal of Biological Chemistry
IS - 12
ER -